Related Experiment Video

Updated: Aug 6, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention

Sundeep Mishra1, William W Chu, Rebecca Torguson

  • 1Division of Cardiology, Washington Hospital Center, Washington, DC, USA.

Insights

Prophylactic intra-aortic balloon pump (IABP) use in high-risk percutaneous coronary interventions (PCIs) improves outcomes. Patients receiving a prophylactic IABP had lower mortality and major adverse cardiac events at six months compared to those needing a rescue IABP.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Intra-aortic balloon pump (IABP) use is established for hemodynamic support during high-risk percutaneous coronary interventions (PCIs).
  • Longer-term outcomes for prophylactic versus rescue IABP strategies in high-risk PCI patients remain incompletely understood.

Purpose of the Study:

  • To compare the clinical outcomes of high-risk PCI patients who received a prophylactic IABP (P-IABP) versus those who required a rescue IABP (R-IABP) due to intraprocedural complications.

Main Methods:

  • A comparative study of 68 patients undergoing high-risk PCI with P-IABP versus 46 patients requiring R-IABP.
  • Exclusion criteria included cardiogenic shock, acute ST-segment elevation myocardial infarction, and mechanical ventilation.
  • Outcomes assessed included procedural success, in-hospital mortality, major complications, and 6-month mortality and major adverse cardiac events.

Main Results:

  • The P-IABP group demonstrated higher procedural success rates and lower in-hospital mortality and major complications compared to the R-IABP group.
  • At 6 months, the P-IABP group had significantly lower mortality (8% vs. 29%) and major adverse cardiac event rates (12% vs. 32%).
  • Prophylactic IABP insertion was identified as the sole independent predictor of 6-month survival. Vascular complication rates were low, with higher major bleeding in the R-IABP group.

Conclusions:

  • Prophylactic IABP support in high-risk PCI patients is associated with favorable short-term and 6-month outcomes compared to rescue IABP.
  • Liberal consideration of prophylactic IABP use in selected high-risk PCI patients is warranted to improve survival and reduce adverse events.